semaglutide cardiovascular news today VisualAbstract: and Outcomes in Obesity without Diabetes π¨ Breaking News: Real-World Data
Description
Subscribe to our weekly newsletter Get the latest scientific articles on interventional cardiology
The mean difference between semaglutide and metformin was statistically significant, with an estimated mean difference of + 1.1 (95% CI, 0.2 to 1.9
Farxiga is approved to reduce the risk of hospitalization for heart failure in adults with T2DM and known heart disease or multiple cardiovascular risk factors (high blood pressure, high cholesterol, or obesity)
Better Results When Combined With Lifestyle Changes Compounded Semaglutide works best alongside realistic nutrition and lifestyle adjustments
doi: 10.3233/JPD-181329
